Cargando…

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1

More than 40 monoclonal antibodies (mAbs) have been approved for a number of disease indications with only one of these (Synagis) — for a viral disease, and not for therapy but for prevention. However, in the last decade novel potent mAbs have been discovered and characterized with potential as ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhongyu, Prabakaran, Ponraj, Chen, Weizao, Broder, Christopher C., Gong, Rui, Dimitrov, Dimiter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SP Wuhan Institute of Virology, CAS 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090799/ https://www.ncbi.nlm.nih.gov/pubmed/23575729 http://dx.doi.org/10.1007/s12250-013-3313-x

Ejemplares similares

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
por: Prabakaran, Ponraj, et al.
Publicado: (2012)

Antibody Aggregation: Insights from Sequence and Structure
por: Li, Wei, et al.
Publicado: (2016)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017)

454 antibody sequencing - error characterization and correction
por: Prabakaran, Ponraj, et al.
Publicado: (2011)

Human Monoclonal Antibodies Against HIV and Emerging Viruses
por: Dimitrov, Dimiter S.
Publicado: (2008)

Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
por: Chen, Weizao, et al.
Publicado: (2012)

Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins
por: Chen, Weizao, et al.
Publicado: (2010)

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
por: Xiao, Xiaodong, et al.
Publicado: (2009)

Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity
por: Wan, Chao, et al.
Publicado: (2013)

Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-binding Domain Complexed with Neutralizing Antibody
por: Prabakaran, Ponraj, et al.
Publicado: (2006)

Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
por: Xiao, Xiaodong, et al.
Publicado: (2009)

A model of the ACE2 structure and function as a SARS-CoV receptor
por: Prabakaran, Ponraj, et al.
Publicado: (2004)

Structure of an isolated unglycosylated antibody C(H)2 domain
por: Prabakaran, Ponraj, et al.
Publicado: (2008)

The SARS Coronavirus S Glycoprotein Receptor Binding Domain: Fine Mapping and Functional Characterization
por: Chakraborti, Samitabh, et al.
Publicado: (2005)

A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
por: Bossart, Katharine N., et al.
Publicado: (2009)

Antibody-based therapeutics against components of the IGF system
por: Feng, Yang, et al.
Publicado: (2012)

Interactions of IgG1 CH2 and CH3 Domains with FcRn
por: Ying, Tianlei, et al.
Publicado: (2014)

Editorial: Therapeutic antibody domains against cancer
por: Zhao, Qi, et al.
Publicado: (2023)

A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity
por: Feng, Yang, et al.
Publicado: (2011)

Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody
por: Xu, Kai, et al.
Publicado: (2013)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro
por: Wang, Hongqian, et al.
Publicado: (2019)

HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions
por: Qi, Qianqian, et al.
Publicado: (2017)

Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn
por: Gong, Rui, et al.
Publicado: (2012)

Human antibody V(H) domains targeting uPAR as candidate therapeutics for cancers
por: Chu, Xiaojie, et al.
Publicado: (2023)

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
por: Saha, Nayanendu, et al.
Publicado: (2021)

Human antibodies targeting ENPP1 as candidate therapeutics for cancers
por: Chu, Xiaojie, et al.
Publicado: (2023)

Human Antibody V(H) Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for Cancers
por: Chu, Xiaojie, et al.
Publicado: (2023)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

Identification of human monoclonal antibodies specific for CCR5 from an antibody library derived from HIV-infected long-term non-progressors
por: Zhang, Mei-Yun, et al.
Publicado: (2006)

Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model
por: Xiao, Xiaodong, et al.
Publicado: (2010)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
por: Li, Wei, et al.
Publicado: (2017)

Editorial: Next-Generation Sequencing of Human Antibody Repertoires for Exploring B-cell Landscape, Antibody Discovery and Vaccine Development
por: Prabakaran, Ponraj, et al.
Publicado: (2020)

Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases
por: Chu, Xiaojie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3350p98elrdr5tbmjbenv84evq